We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$41.2B
AUM Growth
+$785M
Cap. Flow
-$197M
Cap. Flow %
-0.48%
Top 10 Hldgs %
16.49%
Holding
2,297
New
154
Increased
708
Reduced
1,158
Closed
139

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$171M
2
RF icon
Regions Financial
RF
+$151M
3
BABA icon
Alibaba
BABA
+$109M
4
KO icon
Coca-Cola
KO
+$75.9M
5
AMCR icon
Amcor
AMCR
+$67.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 14.7%
3 Financials 10.86%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBM
1651
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$60K ﹤0.01%
3,395
+2,487
+274% +$35.7K
DF
1652
DELISTED
Dean Foods Company
DF
$60K ﹤0.01%
64,830
-9,368
-13% -$15.1K
CVI icon
1653
CVR Energy
CVI
$3.83B
$59K ﹤0.01%
1,188
-232
-16% -$10.4K
NBN icon
1654
Northeast Bank
NBN
$1.05B
$59K ﹤0.01%
2,146
+156
+8% +$3.3K
ATNX
1655
DELISTED
Athenex, Inc. Common Stock
ATNX
$59K ﹤0.01%
148
-21
-12% -$5.82K
CASH icon
1656
Pathward Financial
CASH
$1.85B
$57K ﹤0.01%
2,021
+1,728
+590% +$44K
GBX icon
1657
The Greenbrier Companies
GBX
$1.52B
$57K ﹤0.01%
1,869
-162
-8% -$5.14K
BEAT
1658
DELISTED
BioTelemetry, Inc.
BEAT
$57K ﹤0.01%
1,183
-153,939
-99% -$8.09M
FANG icon
1659
Diamondback Energy
FANG
$56.2B
$56K ﹤0.01%
516
-3,060
-86% -$319K
GTHX
1660
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$56K ﹤0.01%
1,832
-207
-10% -$4.36K
WCG
1661
DELISTED
Wellcare Health Plans, Inc.
WCG
$56K ﹤0.01%
195
-435
-69% -$120K
DNTH icon
1662
Dianthus Therapeutics
DNTH
$6.16B
$55K ﹤0.01%
+232
New +$57.4K
ESPR
1663
DELISTED
Esperion Therapeutics
ESPR
$54K ﹤0.01%
+1,164
New +$54.7K
LHCG
1664
DELISTED
LHC Group LLC
LHCG
$54K ﹤0.01%
454
-89
-16% -$10K
MFSF
1665
DELISTED
MutualFirst Financial Inc
MFSF
$54K ﹤0.01%
1,578
GCO icon
1666
Genesco
GCO
$429M
$53K ﹤0.01%
+1,244
New +$55K
RCUS icon
1667
Arcus Biosciences
RCUS
$3.55B
$53K ﹤0.01%
6,587
+840
+15% +$8.41K
SNR
1668
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$53K ﹤0.01%
7,942
+715
+10% +$4.39K
LCII icon
1669
LCI Industries
LCII
$2.5B
$52K ﹤0.01%
580
+138
+31% +$12.2K
RCM
1670
DELISTED
R1 RCM Inc. Common Stock
RCM
$52K ﹤0.01%
+4,109
New +$46.4K
BHE icon
1671
Benchmark Electronics
BHE
$2.85B
$51K ﹤0.01%
2,056
-3,253
-61% -$83.6K
EFX icon
1672
Equifax
EFX
$20.7B
$51K ﹤0.01%
380
+186
+96% +$23.3K
EGOV
1673
DELISTED
NIC Inc
EGOV
$51K ﹤0.01%
3,204
+1,486
+86% +$24.6K
MNTA
1674
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$51K ﹤0.01%
4,060
-913
-18% -$12.1K
JWN
1675
DELISTED
Nordstrom
JWN
$50K ﹤0.01%
1,557
-22
-1% -$828

Similar funds

Federated Hermes's Q2 2019 Portfolio in Review

As of Q2 2019, Federated Hermes held 2,297 positions worth $41.2B, up 1.9% from $40.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2019 filing shows 154 new, 708 increased, 1,158 reduced and 139 closed positions. Its largest new stake was Amcor: 1,210,171 shares worth $69.5M. The largest sale was American Electric Power, an estimated $183M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q2 2019 buy was Amcor: 1,210,171 shares worth $69.5M.
  • Federated Hermes added most to Pfizer in Q2 2019, an estimated $171M increase.
  • Federated Hermes's biggest Q2 2019 reduction was American Electric Power, cutting an estimated $183M.
  • Federated Hermes fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $41.2B portfolio in Q2 2019.
  • Federated Hermes opened 154 new positions and closed 139 in Q2 2019.
  • Federated Hermes's portfolio value rose 1.9% quarter-over-quarter to $41.2B.

Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.